| GOLDMAN SACHS US ENHANCED EQUITY I CAP EUR | RVI USA | 17,25% | 62,11% | 77,81% | 260,61% |
| IBERCAJA FINANCIERO, FI B | RVI FINANCIERO | 23,15% | 83,89% | 77,81% | 123,14% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 50,60% | 78,20% | 77,79% | 207,06% |
| ROBECO BP US PREMIUM EQUITIES I USD | RVI USA VALOR | 28,01% | 50,28% | 77,78% | 187,30% |
| INVESCO GLOBAL EQUITY INCOME A DIS ANNUAL EUR | RVI GLOBAL | 16,59% | 53,39% | 77,76% | 141,71% |
| ROBECO BP US PREMIUM EQUITIES K USD | RVI USA VALOR | 28,01% | 50,26% | 77,74% | 187,30% |
| ISHARES NORTH AMERICA EQUITY INDEX FUND (LU) X2 EUR CAP | RVI USA | 19,66% | 64,04% | 77,72% | 274,17% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | RVI BIOTECNOLOGÍA | 51,21% | 78,15% | 77,69% | 208,57% |
| GOLDMAN SACHS US TECHNOLOGY OPPORTUNITIES EQUITY PORTFOLIO P USD CAP | RVI TECNOLOGÍA | 26,86% | 91,42% | 77,67% | · |
| ISHARES EDGE MSCI WORLD MOMENTUM FACTOR UCITS ETF USD (ACC) | RVI GLOBAL | 27,08% | 89,00% | 77,67% | 289,71% |
